These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34364050)

  • 1. Synthesis and kinetic characterization of hyperbolic inhibitors of human cathepsins K and S based on a succinimide scaffold.
    Goričan T; Ciber L; Petek N; Svete J; Novinec M
    Bioorg Chem; 2021 Oct; 115():105213. PubMed ID: 34364050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of succinimide derivatives as potential mechanism-based inhibitors of human leukocyte elastase, cathepsin G and proteinase 3.
    Groutas WC; Brubaker MJ; Chong LS; Venkataraman R; Huang H; Epp JB; Kuang R; Hoidal JR
    Bioorg Med Chem; 1995 Apr; 3(4):375-81. PubMed ID: 8581420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New chemotypes for cathepsin K inhibitors.
    Teno N; Irie O; Miyake T; Gohda K; Horiuchi M; Tada S; Nonomura K; Kometani M; Iwasaki G; Betschart C
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2599-603. PubMed ID: 18375120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Sulfonyl dipeptide nitriles as inhibitors of human cathepsin S: In silico design, synthesis and biochemical characterization.
    Lemke C; Cianni L; Feldmann C; Gilberg E; Yin J; Dos Reis Rocho F; de Vita D; Bartz U; Bajorath J; Montanari CA; Gütschow M
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127420. PubMed ID: 32763808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic Characterization of Cerium and Gallium Ions as Inhibitors of Cysteine Cathepsins L, K, and S.
    Novinec M; Bembič P; Janković M; Kisilak M; Kljun J; Turel I
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and kinetic evaluation of ethyl acrylate and vinyl sulfone derived inhibitors for human cysteine cathepsins.
    Breuer C; Lemke C; Schmitz J; Bartz U; Gütschow M
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2008-2012. PubMed ID: 29748052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of proline analogues as potent and selective cathepsin S inhibitors.
    Kim M; Jeon J; Song J; Suh KH; Kim YH; Min KH; Lee KO
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3140-4. PubMed ID: 23639544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cathepsin k inhibitor basicity on in vivo off-target activities.
    Desmarais S; Black WC; Oballa R; Lamontagne S; Riendeau D; Tawa P; Duong LT; Pickarski M; Percival MD
    Mol Pharmacol; 2008 Jan; 73(1):147-56. PubMed ID: 17940194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs.
    Tber Z; Wartenberg M; Jacques JE; Roy V; Lecaille F; Warszycki D; Bojarski AJ; Lalmanach G; Agrofoglio LA
    Bioorg Med Chem; 2018 Aug; 26(14):4310-4319. PubMed ID: 30049585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
    Robichaud J; Oballa R; Prasit P; Falgueyret JP; Percival MD; Wesolowski G; Rodan SB; Kimmel D; Johnson C; Bryant C; Venkatraman S; Setti E; Mendonca R; Palmer JT
    J Med Chem; 2003 Aug; 46(17):3709-27. PubMed ID: 12904076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors.
    Rydzewski RM; Bryant C; Oballa R; Wesolowski G; Rodan SB; Bass KE; Wong DH
    Bioorg Med Chem; 2002 Oct; 10(10):3277-84. PubMed ID: 12150873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.
    Black WC; Percival MD
    Chembiochem; 2006 Oct; 7(10):1525-35. PubMed ID: 16921579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
    Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of cathepsins K and S identified using the DynaMAD virtual screening algorithm.
    Stumpfe D; Sisay MT; Frizler M; Vogt I; Gütschow M; Bajorath J
    ChemMedChem; 2010 Jan; 5(1):61-4. PubMed ID: 20013988
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.
    Yasuda Y; Kaleta J; Brömme D
    Adv Drug Deliv Rev; 2005 May; 57(7):973-93. PubMed ID: 15876399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin K.
    Fenwick AE; Gribble AD; Ife RJ; Stevens N; Witherington J
    Bioorg Med Chem Lett; 2001 Jan; 11(2):199-202. PubMed ID: 11206458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylamine based cathepsin K inhibitors: investigating P3 heterocyclic substituents.
    Shinozuka T; Shimada K; Matsui S; Yamane T; Ama M; Fukuda T; Taki M; Takeda Y; Otsuka E; Yamato M; Naito S
    Bioorg Med Chem; 2006 Oct; 14(20):6807-19. PubMed ID: 16829073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.